Skip to main content

GSA CAPITAL PARTNERS LLP

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1362033 LONDON, X0

Position in SRPT

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$1,979,289
+$464,906 QoQ
Shares Held
90,960
+29.3% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
17 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SRPT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $100,995,552 across 161 Biotechnology names. SRPT ranks #7 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 SRPT
Sarepta Therapeutics, Inc.
This page
90,960 $1,979,289

All Filings in SRPT

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,979,289 90,960
2025-12-31 $1,514,383 70,371
2025-09-30 $396,287 20,565
2025-06-30 $1,070,887 62,625
2025-03-31 $1,457,776 22,842
2024-06-30 $457,568 2,896
2024-03-31 $654,031 5,052
2023-12-31 $640,391 6,641
2023-09-30 $826,114 6,815
2022-12-31 $794,843 6,134
2022-09-30 $803,625 7,270
2022-06-30 $346,090 4,617
2022-03-31 $455,595 5,832
2021-12-31 $723,731 8,037
2021-06-30 $264,549 3,403
2020-12-31 $259,144 1,520
2020-09-30 $441,511 3,144